NCT03736031

Brief Summary

Despite being strongly recommended, the integration of palliative care in oncology has not been widely adopted. Very few people have access to comprehensive palliative care. Access is even lower in rural and Hispanic communities. Even in communities with access, uptake is often low due to a lack of education on the part of both patients and providers regarding palliative care. This study aims to use an innovative approach to provide quality palliative care to oncology Hispanic patients by using community health workers also known as promotoras.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 4, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

May 8, 2018

Completed
6 months until next milestone

First Posted

Study publicly available on registry

November 8, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 4, 2019

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
4 months until next milestone

Results Posted

Study results publicly available

October 26, 2020

Completed
Last Updated

October 26, 2020

Status Verified

October 1, 2020

Enrollment Period

1.4 years

First QC Date

April 4, 2018

Results QC Date

August 17, 2020

Last Update Submit

October 1, 2020

Conditions

Keywords

cancer

Outcome Measures

Primary Outcomes (2)

  • Patient Health Questionnaire - 9 (PHQ-9)

    Patient Health Questionnaire -9 (PHQ-9); the score can range from 0 - 27; the lower score indicates a better outcome

    The PHQ-9 was administered at baseline and then again about six weeks later when study participation is completed..

  • Functional Assessment of Chronic Illness Therapy - Palliative Care (FACIT-Pal)

    Functional Assessment Chronic Illness Therapy (FACIT)-Palliative care (Pal), score range 0-184, a higher score means a better outcome.

    The FACIT-Pal was administered at baseline and then again about six weeks later when study participation is completed.

Secondary Outcomes (2)

  • Emergency Department Visits

    six weeks after enrollment

  • Intensive Care Unit Admissions

    six weeks after enrollment

Study Arms (2)

Intervention (Promotora)

EXPERIMENTAL

The intervention group will have three face-to-face meetings with the promotora. Participant will continue to receive the standard of care for his or her oncologic diagnosis as determined by his or her treating oncologist over the course of the study. During the study period, all participants will complete baseline, interim and exit surveys covering demographics, quality of life and pain management. Information pertaining to hospitalizations and emergency room visits will be obtained from their medical records and public health records.

Behavioral: Intervention (Promotora)

Self-Education (Control)

NO INTERVENTION

Participant will receive the standard of care for his or her oncologic diagnosis as determined by his or her treating oncologist over the course of the study. During the study period, all participants will complete baseline, interim and exit surveys covering demographics, quality of life and pain management. Information pertaining to hospitalizations and emergency room visits will be obtained from their medical records and public health records.

Interventions

If the patient is in the intervention group, the promotora will call the patient in order to invite them to a meeting. Meetings will be arranged by the promotora and the patients. A total of 2 group meetings will be required by all participants and 1 family meeting.

Intervention (Promotora)

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be 18 years or older
  • Must be a Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) or University Medical Center (UMC) El Paso patient
  • Must be Hispanic
  • Must have a cancer diagnosis

You may not qualify if:

  • Under 17 years of age
  • Not Hispanic
  • Is not a patient of UMC or TTUHSC El Paso

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Texas Tech University Health Sciences Center El Paso

El Paso, Texas, 79905, United States

Location

MeSH Terms

Conditions

Neoplasms

Interventions

Methods

Intervention Hierarchy (Ancestors)

Investigative Techniques

Results Point of Contact

Title
Associate Director of Ob/Gyn Research
Organization
Texas Tech University Health Sciences Center at El Paso

Study Officials

  • Christina Bracamontes, MS

    Texas Tech University HSC El Paso

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 4, 2018

First Posted

November 8, 2018

Study Start

May 8, 2018

Primary Completion

October 4, 2019

Study Completion

June 30, 2020

Last Updated

October 26, 2020

Results First Posted

October 26, 2020

Record last verified: 2020-10

Locations